Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MALLINCKRODT PLC

(MNKKQ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about MALLINCKRODT PLC
11/23NORTH AMERICAN MORNING BRIEFING : Stock Futures Slip, Yields Rise After Powell's Fed Nomin..
DJ
11/23EMEA MORNING BRIEFING : Stocks to Track Wall -2-
DJ
11/05Kathy Schaefer Issues Resignation from Mallinckrodt plc as Senior Vice President of Fin..
CI
11/05Regulation FD Disclosure - Form 8-K
PU
11/03Mallinckrodt plc Announces Executive Changes
CI
11/02Net Debt Leverage Q3 2021 11-02-2021
PU
11/02Non-GAAP Definitions Q3 2021 11-02-2021
PU
11/02Third Quarter Financial Results - Form 8-K
PU
11/02NORTH AMERICAN MORNING BRIEFING : Stock Futures Steady After Wall Street Records
DJ
11/01ANI Pharma Shares Take Flight as FDA Approves Return of Cortrophin Gel
DJ
11/01ANI Pharmaceuticals Gets FDA OK to Bring Back Cortrophin Gel
DJ
10/28Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations i..
PU
10/26SUBJECT TO FRE 408, STATE LAW EQUIVA : Refresh of 2021 Strategic Plan September 2021 - For..
PU
10/25Mallinckrodt plc Presents Results on Real World Treatment Patterns and Outcomes in Hosp..
CI
10/15PRO BANKRUPTCY BRIEFING : J&J Unit Files Bankruptcy Over Talc Claims; Purdue Appeals to Be..
DJ
10/04U.S. Supreme Court rejects challenge to New York tax on opioid companies
RE
10/04U.S. Supreme Court rejects challenge to New York tax on opioid companies
RE
09/03Mallinckrodt Reaches Settlement Agreement With More Creditors
DJ
09/02MALLINCKRODT : Presents Interim Results on Real World Use of Extracorporeal Photopheresis ..
PU
08/31ANI PHARMACEUTICALS : FDA Accepts Application for Cortrophin Gel Revival
DJ
08/13Mallinckrodt Provides Information to the Shareholders
CI
08/05Buxton Helmsley Sends Letter to Mallinckrodt plc
CI
08/03MALLINCKRODT : Net Debt Leverage Q2 2021 08-03-2021
PU
08/03MALLINCKRODT : Non-GAAP Definitions Q2 2021 08-03-2021
PU
08/03MALLINCKRODT : Second Quarter Financial Results (Form 8-K)
PU
08/03Mallinckrodt plc Reports Earnings Results for the Second Quarter Ended June 25, 2021
CI
08/03TRANCHE UPDATE ON MALLINCKRODT PLC ( : MNKK.Q)'s Equity Buyback Plan announced on March 1,..
CI
08/02Buxton Helmsley Provides Information to the Shareholders
CI
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties, cities fo..
RE
07/21U.S. state officials urge support for landmark $26 billion opioid settlement
RE
07/21Drugmakers, pharmacies next targets for U.S. opioid settlements
RE
07/20MARKET CHATTER : Endo Pharmaceuticals Soars After Drug Maker Reportedly Proposes Settlemen..
MT
07/19U.S. states to unveil $26 billion opioid settlement with drug distributors, J&J - sourc..
RE
07/07Mallinckrodt plc Announces Publication of Phase 3 STRATA2016 Study in Burns
CI
07/02MALLINCKRODT : Announces Inclusion of Acthar Gel (Repository Corticotropin Injection) in N..
AQ
07/01MALLINCKRODT : Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection) in ..
PR
07/01Mallinckrodt plc Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection..
CI
06/30AMBRX BIOPHARMA : Names Sonja Nelson Finance Chief
MT
06/24MALLINCKRODT PLC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibi..
AQ
06/15Mallinckrodt Announces U.S. FDA Approval of StrataGraft®
CI
06/15Second Amended Joint Reorganization Plan and Further Revised Disclosure Statement Filed..
CI
06/14MALLINCKRODT PLC : Regulation FD Disclosure (form 8-K)
AQ
06/08First Amended Joint Reorganization Plan and Revised Disclosure Statement Filed by Malli..
CI
05/19Motion for Asset Sale Filed by Mallinckrodt plc
CI
05/04MALLINCKRODT : Presents Data Evaluating Acthar Gel (Repository Corticotropin Injection) fo..
AQ
05/04MALLINCKRODT : 2020 Irish Statutory Accounts
PU
05/04MALLINCKRODT : First Quarter Financial Results
PU
05/04MALLINCKRODT : Non-GAAP Definitions Q1 2021 05-04-2021
PU
05/04MALLINCKRODT : Net Debt Leverage Q1 2021 05-04-2021
PU
05/04MALLINCKRODT : Management's Discussion and Analysis of Financial Condition and Results of ..
AQ
05/04Mallinckrodt plc Reports Earnings Results for the First Quarter Ended March 26, 2021
CI
05/04TRANCHE UPDATE ON MALLINCKRODT PLC ( : MNKK.Q)'s Equity Buyback Plan announced on March 1,..
CI
05/03MALLINCKRODT : Presents Data Evaluating INOmax (Nitric Oxide) Gas, for Inhalation in a Pha..
AQ
05/03MALLINCKRODT : Presents Data Evaluating Acthar® Gel (Repository Corticotropin Injection) f..
PR
05/03Mallinckrodt Presents Data Evaluating Acthar Gel for the Treatment of Severe Keratitis ..
CI
05/02MALLINCKRODT : Acthar Gel Phase 4 Keratitis ARVO Poster
PU
04/30MALLINCKRODT : Presents Data Evaluating INOmax® (Nitric Oxide) Gas, for Inhalation in a Ph..
PR
04/30Mallinckrodt plc Presents Data Evaluating Inomax® (Nitric Oxide) Gas, for Inhalation in..
CI
04/28Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Coll..
CI
04/20Joint Reorganization Plan and Disclosure Statement Filed by Mallinckrodt plc
CI
03/30Silence Therapeutics Posts Bigger FY20 Loss On Higher Expenses
MT
03/24MALLINCKRODT : Supports Healthcare Businesswomen's Association as Two Employees Honored wi..
PU
03/22MALLINCKRODT : Announces U.S. Food and Drug Administration (FDA) Approves Updated Acthar® ..
PU
03/17MALLINCKRODT : Announces 2021 Advancing Extracorporeal Photopheresis Immunomodulation Inve..
PU
03/10Buxton Helmsley Sends Letter to Mallinckrodt plc
CI
03/10TRANCHE UPDATE ON MALLINCKRODT PLC ( : MNKK.Q)'s Equity Buyback Plan announced on March 1,..
CI
03/10MALLINCKRODT : Non-GAAP Definitions Q4 2020 03-10-2021
PU
03/10MALLINCKRODT : Net Debt Leverage Q4 2020 03-10-2021
PU
03/10Mallinckrodt plc Auditor Raises 'Going Concern' Doubt
CI
03/08MALLINCKRODT : Initial Insider Trading Report (SEC Filing - 3)
PU
03/04Mallinckrodt Announces New England Journal of Medicine Publication of Results from its ..
CI
02/26Silence Therapeutics plc & Mallinckrodt plc Initiate Work on 3Rd Target
CI
02/24First Motion for Exclusivity Period Extension Approved For Mallinckrodt plc
CI
02/12Mallinckrodt Provides Regulatory Update on StrataGraft®
CI
02/10MALLINCKRODT : Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on MALLINCKRODT PLC
05/10/22